John Choi, MD
Ophthalmology · Waldorf, MDNPI 1114981149
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $140,875 of the $141,452 with a category attached, or 99.6%. Globus Medical accounts for 99.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $93,229, more than ten times the $309 reported in 2019. Among ophthalmology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $2886.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$141K
- AbbVie$153
- Novartis$138
- Novo Nordisk$124
- Regeneron Healthcare Solutions, Inc.$57
- Alcon$52
- plus $54 from 2 others
What the payments were for
- Consulting fees$140,875100%
- Food & beverage$5580%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 37 | $140,875 |
| AbbVie(2 entities) | 3 | $153 |
| Novartis | 2 | $138 |
| Novo Nordisk | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Alcon | 2 | $52 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Excelsius - GPS$45,250
- XLIF$39,575
- ExcelsiusGPS Robotic Navigation System$20,700
- ELSA$14,850
- CREO$11,400
- ALIF$7,150
- RYBELSUS$124
- OZURDEX$119
How this compares
$141,452 in reported general payments places this provider in the 95th percentile of 493 ophthalmology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 52 | $3,127 |
| Ketorolac Tromethamine | 37 | $912 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $737 |
| MoxifloxacinMoxifloxacin Hcl | 21 | $565 |
| ErythromycinErythromycin Base | 18 | $178 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Waldorf
- Alfred SommerBaltimore$2.9M
- Richard AdlerBaltimore$2.7M
- Peter McDonnellBaltimore$1.4M
- Esen AkpekBaltimore$782K
- Lisa FeulnerBel Air$434K
- Allen HuHagerstown$379K
- Susan BresslerLutherville$341K
- Renee BovelleGlenn Dale$292K
- Neil BresslerBaltimore$265K
- Scott LaborwitTowson$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.